LEADER 02219oam  2200505   450 
001 9910137538703321
005 20230621135327.0
010   $a9782889195350$b(eBook)
035   $a(CKB)3710000000569638
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/39880
035   $a(EXLCZ)993710000000569638
100   $a20191103h20152015  fy|            0
101 0 $aeng
135   $aur||#---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$a2015$eWhich new directions for Alzheimer's disease? /$fedited by Ludovic Martin
210   $cFrontiers Media SA$d2015
210  1$a[Lausanne, Switzerland] :$cFrontiers Media SA,$d[2015]
210  4$dİ2015
215   $a1 online resource (122 pages) $cillustrations (some colour); digital file(s)
225 1 $aFrontiers Research Topics
311 08$aPrint version: Martin, Ludovic. 2015: which new directions for Alzheimer's disease? [Place of publication not identified]  : Frontiers Media SA, 2015 288919535X 
320   $aIncludes bibliographical references.
330   $aIn this Research Topic, we wish to summarize and review the etiology of AD and the related therapeutic opportunities for the next decades. To fully understand the precise mechanisms underlying AD, research findings, reviews, new insights and new approaches include AD and related tauopathies, tau phosphorylation balance, pharmacological compounds against AD, neuroprotection strategies and new therapeutic ways but also risk factors for AD and AD genetic information are included in this issue.
410  0$aFrontiers research topics.
517 3 $aWhich new directions for Alzheimer's disease?
606   $aAlzheimer's disease$xResearch
610   $akinase inhibitors
610   $aTherapeutics
610   $atau
610   $aTREM2
610   $aAlzheimers disease
610   $amicrobiome
610   $aA? peptides
615  0$aAlzheimer's disease$xResearch.
676   $a616.831
700   $aLudovic Martin$4auth$01366152
702   $aMartin$b Ludovic$f1982-
801  0$bUkMaJRU
906   $aBOOK
912   $a9910137538703321
996   $a2015$93388670
997   $aUNINA